The sample is not the batch
A result on one vial generalises to a batch only if the vial was drawn in a way that makes it representative — and nobody records how it was drawn.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 8 of 48 of this archive, newest first.
A result on one vial generalises to a batch only if the vial was drawn in a way that makes it representative — and nobody records how it was drawn.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Follow the resin, not the catalogue.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Duplicate submissions under different names test within-laboratory repeatability, which is a different quantity from between-laboratory reproducibility.
A reminder that a purity figure is the output of a method, and that methods differ.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.